tiprankstipranks
Trending News
More News >
Phibro Animal Health (PAHC)
NASDAQ:PAHC
US Market

Phibro Animal Health (PAHC) Ratios

Compare
90 Followers

Phibro Animal Health Ratios

PAHC's free cash flow for Q3 2025 was $0.30. For the 2025 fiscal year, PAHC's free cash flow was decreased by $ and operating cash flow was $0.11. See a summary of the company’s cash flow.
Ratios
TTM
Jun 24Jun 23Jun 22Jun 21
Liquidity Ratios
Current Ratio
3.33 3.33 2.97 3.04 2.87
Quick Ratio
1.75 1.75 1.61 1.72 1.62
Cash Ratio
0.23 0.23 0.39 0.31 0.23
Solvency Ratio
0.10 0.10 0.12 0.14 0.11
Operating Cash Flow Ratio
0.08 0.08 0.17 0.29 0.38
Short-Term Operating Cash Flow Coverage
0.49 0.49 2.11 3.80 2.69
Net Current Asset Value
$ -103.17M$ -103.17M$ -103.03M$ -103.89M$ -144.06M
Leverage Ratios
Debt-to-Assets Ratio
0.52 0.52 0.50 0.51 0.52
Debt-to-Equity Ratio
1.81 1.81 1.79 1.79 2.18
Debt-to-Capital Ratio
0.64 0.64 0.64 0.64 0.69
Long-Term Debt-to-Capital Ratio
0.62 0.62 0.61 0.62 0.66
Financial Leverage Ratio
3.44 3.44 3.55 3.53 4.17
Debt Service Coverage Ratio
2.11 2.11 3.41 3.65 2.29
Interest Coverage Ratio
4.00 4.00 3.89 3.33 2.86
Debt to Market Cap
0.86 0.86 0.56 0.34 0.37
Interest Debt Per Share
13.03 13.03 11.91 10.86 10.47
Net Debt to EBITDA
4.02 4.02 3.45 3.57 3.66
Profitability Margins
Gross Profit Margin
30.50%30.50%30.29%32.57%32.10%
EBIT Margin
7.35%7.35%8.96%8.98%8.65%
EBITDA Margin
11.93%11.93%12.18%12.66%12.76%
Operating Profit Margin
7.35%7.35%4.91%5.16%4.61%
Pretax Profit Margin
5.53%5.53%7.67%7.98%6.93%
Net Profit Margin
3.33%3.33%5.22%6.53%4.19%
Continuous Operations Profit Margin
3.33%3.33%5.22%6.53%4.19%
Net Income Per EBT
60.30%60.30%68.02%81.78%60.45%
EBT Per EBIT
75.26%75.26%156.17%154.60%150.57%
Return on Assets (ROA)
3.36%3.36%5.28%6.46%4.28%
Return on Equity (ROE)
11.54%11.54%18.74%22.80%17.83%
Return on Capital Employed (ROCE)
9.03%9.03%6.25%6.35%5.88%
Return on Invested Capital (ROIC)
5.23%5.23%4.13%5.05%3.39%
Return on Tangible Assets
3.78%3.78%6.04%7.49%5.08%
Earnings Yield
5.88%5.88%6.35%4.65%3.16%
Efficiency Ratios
Receivables Turnover
5.98 5.98 5.66 5.68 6.33
Payables Turnover
9.20 9.20 6.87 8.22 8.73
Inventory Turnover
2.45 2.45 2.53 2.60 2.76
Fixed Asset Turnover
4.23 4.23 4.64 4.44 4.68
Asset Turnover
1.01 1.01 1.01 0.99 1.02
Working Capital Turnover Ratio
2.49 2.49 2.65 2.65 2.64
Cash Conversion Cycle
170.42 170.42 155.39 160.40 147.95
Days of Sales Outstanding
61.02 61.02 64.51 64.32 57.70
Days of Inventory Outstanding
149.07 149.07 144.00 140.49 132.07
Days of Payables Outstanding
39.66 39.66 53.12 44.40 41.82
Operating Cycle
210.09 210.09 208.51 204.80 189.77
Cash Flow Ratios
Operating Cash Flow Per Share
0.33 0.33 0.78 1.19 1.47
Free Cash Flow Per Share
-0.95 -0.95 -0.13 0.47 0.63
CapEx Per Share
1.28 1.28 0.91 0.72 0.84
Free Cash Flow to Operating Cash Flow
-2.89 -2.89 -0.17 0.39 0.43
Dividend Paid and CapEx Coverage Ratio
0.19 0.19 0.56 0.99 1.11
Capital Expenditure Coverage Ratio
0.26 0.26 0.85 1.65 1.74
Operating Cash Flow Coverage Ratio
0.03 0.03 0.07 0.11 0.14
Operating Cash Flow to Sales Ratio
0.01 0.01 0.03 0.06 0.07
Free Cash Flow Yield
-6.94%-6.94%-0.70%1.62%2.38%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
17.02 17.02 15.76 21.49 31.67
Price-to-Sales (P/S) Ratio
0.57 0.57 0.82 1.40 1.33
Price-to-Book (P/B) Ratio
1.96 1.96 2.95 4.90 5.65
Price-to-Free Cash Flow (P/FCF) Ratio
-14.42 -14.42 -143.62 61.56 42.00
Price-to-Operating Cash Flow Ratio
41.69 41.69 24.48 24.20 17.91
Price-to-Earnings Growth (PEG) Ratio
-0.51 -0.51 -1.62 0.35 -0.82
Price-to-Fair Value
1.96 1.96 2.95 4.90 5.65
Enterprise Value Multiple
8.78 8.78 10.20 14.65 14.07
Enterprise Value
1.02B 1.02B 1.17B 1.55B 1.44B
EV to EBITDA
8.78 8.78 10.20 14.65 14.07
EV to Sales
1.05 1.05 1.24 1.85 1.80
EV to Free Cash Flow
-26.60 -26.60 -217.07 81.39 56.80
EV to Operating Cash Flow
76.90 76.90 37.00 31.99 24.21
Tangible Book Value Per Share
4.30 4.30 3.59 3.05 1.60
Shareholders’ Equity Per Share
6.97 6.97 6.48 5.89 4.65
Tax and Other Ratios
Effective Tax Rate
0.40 0.40 0.32 0.18 0.40
Revenue Per Share
24.14 24.14 23.26 20.59 19.79
Net Income Per Share
0.81 0.81 1.21 1.34 0.83
Tax Burden
0.60 0.60 0.68 0.82 0.60
Interest Burden
0.75 0.75 0.86 0.89 0.80
Research & Development to Revenue
0.02 0.02 0.02 0.02 0.02
SG&A to Revenue
0.00 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
0.00 0.00 0.00 <0.01 <0.01
Income Quality
0.41 0.41 0.64 0.89 1.77
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis